Published in Exp Neurol on September 01, 1998
Spinal cord injury I: A synopsis of the basic science. Can Vet J (2010) 1.58
Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair. Cell Mol Neurobiol (2006) 1.30
Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev (2007) 1.28
Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir Physiol Neurobiol (2009) 1.22
Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release (2006) 1.19
Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol (2007) 1.13
Biomaterials for the central nervous system. J R Soc Interface (2008) 1.08
Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials (2009) 1.05
Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release (2006) 1.04
Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther (2008) 1.03
Sustaining intrinsic growth capacity of adult neurons promotes spinal cord regeneration. Proc Natl Acad Sci U S A (2005) 0.99
Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats. J Anat (2004) 0.95
Axon guidance of outgrowing corticospinal fibres in the rat. J Anat (1999) 0.91
Organic electrode coatings for next-generation neural interfaces. Front Neuroeng (2014) 0.90
Transplantation of D15A-expressing glial-restricted-precursor-derived astrocytes improves anatomical and locomotor recovery after spinal cord injury. Int J Biol Sci (2012) 0.89
Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats. Eur Spine J (2005) 0.86
Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury. Brain Res Bull (2010) 0.84
Dissociated predegenerated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on regeneration and functional recovery compared to Schwann cell transplants. J Neurotrauma (2012) 0.83
From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics (2013) 0.83
Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration. Tissue Eng Part A (2013) 0.81
An overview of tissue engineering approaches for management of spinal cord injuries. J Neuroeng Rehabil (2007) 0.80
Visual bone marrow mesenchymal stem cell transplantation in the repair of spinal cord injury. Neural Regen Res (2015) 0.78
Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological Obstacles. Biomed Res Int (2015) 0.77
Biodegradable biomatrices and bridging the injured spinal cord: the corticospinal tract as a proof of principle. Cell Tissue Res (2012) 0.77
Astrocytes alignment and reactivity on collagen hydrogels patterned with ECM proteins. Biomaterials (2014) 0.76
Dynamic behaviors of astrocytes in chemically modified fibrin and collagen hydrogels. Integr Biol (Camb) (2016) 0.75
Fabrication and characterization of microspheres encapsulating astrocytes for neural regeneration. ACS Biomater Sci Eng (2016) 0.75
Cerebral function in diabetes mellitus. Diabetologia (1994) 2.82
Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma (2001) 2.39
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med (1990) 1.99
Ethology and neurobiology of grooming behavior. Physiol Rev (1992) 1.85
Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res (1998) 1.79
Phosphatidic acid is a specific activator of phosphatidylinositol-4-phosphate kinase. J Biol Chem (1992) 1.78
Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev (2000) 1.71
Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry (1993) 1.67
Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes (1996) 1.61
Power density and exposure time of He-Ne laser irradiation are more important than total energy dose in photo-biomodulation of human fibroblasts in vitro. Lasers Surg Med (1992) 1.59
DOC2 proteins in rat brain: complementary distribution and proposed function as vesicular adapter proteins in early stages of secretion. Neuron (1997) 1.56
Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord (2003) 1.55
Corticotropin-(1--24)-tetracosapeptide affects protein phosphorylation and polyphosphoinositide metabolism in rat brain. Biochem J (1981) 1.53
Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain (2002) 1.51
Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol (2002) 1.45
Pain relief and quality-of-life improvement after spinal cord stimulation in painful diabetic polyneuropathy: a pilot study. Br J Anaesth (2012) 1.44
Nimodipine protects cultured spinal cord neurones from depolarization-induced inhibition of neurite outgrowth. Cell Calcium (1993) 1.41
Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin. Exp Eye Res (1993) 1.38
Rapid determination of the hypoxanthine increase in ischemic exercise tests. Clin Chem (1988) 1.38
The expression of the growth associated protein B50/GAP43 in the olfactory system of neonatal and adult rats. J Neurosci (1989) 1.38
Progress testing with short answer questions. Med Teach (2005) 1.38
B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog Neurobiol (1997) 1.35
CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury. J Neurosci Methods (2008) 1.28
Warm-up, stretching and massage diminish harmful effects of eccentric exercise. Int J Sports Med (1994) 1.24
Pituitary hormones influence polyphosphoinositide metabolism in rat brain. FEBS Lett (1979) 1.21
Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain (2000) 1.21
Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J Neurosci (2003) 1.15
Modulation of brain polyphosphoinositide metabolism by ACTH-sensitive protein phosphorylation. Nature (1980) 1.14
Neuroplasticity in the olfactory system: differential effects of central and peripheral lesions of the primary olfactory pathway on the expression of B-50/GAP43 and the olfactory marker protein. J Neurosci Res (1990) 1.14
Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor. J Neurosci (2001) 1.11
Purification and some characteristics of an ACTH-sensitive protein kinase and its substrate protein in rat brain membranes. J Neurochem (1980) 1.09
Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience (1999) 1.09
Inhibition of noradrenaline release by antibodies to B-50 (GAP-43). Nature (1989) 1.09
Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity. J Neurol Sci (1989) 1.08
Expression of growth-associated protein B-50 (GAP43) in dorsal root ganglia and sciatic nerve during regenerative sprouting. J Neurosci (1989) 1.08
AlphaCaMKII binding to the C-terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation. FEBS Lett (1999) 1.07
Relations between muscle soreness and biochemical and functional outcomes of eccentric exercise. J Appl Physiol (1985) (1993) 1.05
Brain melanocortin receptors: from cloning to function. Peptides (1997) 1.05
Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J Neurosci (2001) 1.03
Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology (1998) 1.03
The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies. Life Sci (1975) 1.03
Aspects of static and dynamic motor function in peripheral nerve regeneration: SSI and CatWalk gait analysis. Behav Brain Res (2010) 1.02
Nerve growth factor-induced changes in the intracellular localization of the protein kinase C substrate B-50 in pheochromocytoma PC12 cells. J Cell Biol (1989) 1.02
ACTH-like peptides and opiate receptors in the rat brain: structure-activity studies. Eur J Pharmacol (1976) 1.01
Methods for producing a reproducible crush in the sciatic and tibial nerve of the rat and rapid and precise testing of return of sensory function. Beneficial effects of melanocortins. J Neurol Sci (1986) 1.01
Effects of enriched housing on functional recovery after spinal cord contusive injury in the adult rat. J Neurotrauma (2001) 1.01
Freeze-substitution and Lowicryl HM20 embedding of fixed rat brain: suitability for immunogold ultrastructural localization of neural antigens. J Histochem Cytochem (1991) 1.01
Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke (2001) 1.00
Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain (1999) 1.00
Phosphorylation of B-50 protein by calcium-activated, phospholipid-dependent protein kinase and B-50 protein kinase. J Neurochem (1983) 1.00
ACTH-induced excessive grooming in the rat. Pharmacol Ther (1981) 1.00
Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia (2000) 0.99
Targeted overexpression of the neurite growth-associated protein B-50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci (1997) 0.99
Prednisone can protect against exercise-induced muscle damage. J Neurol (1996) 0.98
Phosphorylation of the presynaptic protein B-50 (GAP-43) is increased during electrically induced long-term potentiation. Neuron (1992) 0.98
Comparison of the immunocytochemical distribution of the phosphoprotein B-50 in the cerebellum and hippocampus of immature and adult rat brain. Brain Res (1986) 0.98
High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats. Eur J Pharmacol (1999) 0.97
Affinity-purified anti-B-50 protein antibody: interference with the function of the phosphoprotein B-50 in synaptic plasma membranes. J Neurochem (1983) 0.97
Modulation of the activity of purified phosphatidylinositol 4-phosphate kinase by phosphorylated and dephosphorylated B-50 protein. Biochem Biophys Res Commun (1985) 0.97
Cold jet: a method to obtain pure Schwann cell cultures without the need for cytotoxic, apoptosis-inducing drug treatment. J Neurosci Methods (1997) 0.97
Exercise training improves functional recovery and motor nerve conduction velocity after sciatic nerve crush lesion in the rat. Arch Phys Med Rehabil (1997) 0.96
Roles of the basolateral amygdala and hippocampus in social recognition in rats. Physiol Behav (1996) 0.95
Calcium-dependent turnover of brain polyphosphoinositides in vitro after prelabelling in vivo. Biochim Biophys Acta (1981) 0.95
Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res (2004) 0.95
Neuropathic pain: a possible role for the melanocortin system? Eur J Pharmacol (2001) 0.95
The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev (1995) 0.94
Phosphorylation of B-50 (GAP43) is correlated with neurotransmitter release in rat hippocampal slices. J Neurochem (1989) 0.94
Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat. Eur J Pharmacol (1999) 0.94
Melanocortin receptors mediate alpha-MSH-induced stimulation of neurite outgrowth in neuro 2A cells. Brain Res Mol Brain Res (1996) 0.94
ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides (1995) 0.94
B-50/GAP-43 binds to actin filaments without affecting actin polymerization and filament organization. J Neurochem (1993) 0.93
Vasopressin and memory consolidation. Prog Brain Res (1976) 0.93
Purification and partial characterization of the phosphatidylinositol 4-phosphate kinase from rat brain. Biochem J (1984) 0.93
Neurotoxic side-effects of cisplatin. Eur J Cancer (1991) 0.93
Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats. J Neurosci (2000) 0.93
Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates. Prog Neuropsychopharmacol Biol Psychiatry (1997) 0.92
Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus. Eur J Neurosci (2005) 0.92
Temporal differences in the phosphorylation state of pre- and postsynaptic protein kinase C substrates B-50/GAP-43 and neurogranin during long-term potentiation. J Biol Chem (1995) 0.92
The effect of exercise training on functional recovery after sciatic nerve crush in the rat. J Peripher Nerv Syst (1998) 0.92
CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production. J Neuroimmunol (2001) 0.91
Myoglobin is a sensitive marker of increased muscle membrane vulnerability. J Neurol (1990) 0.91
B-50/GAP-43 potentiates cytoskeletal reorganization in raft domains. Mol Cell Neurosci (1999) 0.91
Collagen implants and cortico-spinal axonal growth after mid-thoracic spinal cord lesion in the adult rat. J Neurosci Res (1995) 0.91
Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons. Cancer Res (1990) 0.91
Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia (1992) 0.91
Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J Neurol Sci (2007) 0.90
Presynaptic phosphoprotein B-50/GAP-43 in neuronal and synaptic plasticity. Acta Biochim Pol (1996) 0.90
Differential GABAergic disinhibition during the development of painful peripheral neuropathy. Neuroscience (2011) 0.90
Quantitative EEG changes due to cerebral vasoconstriction. Indomethacin versus hyperventilation-induced reduction in cerebral blood flow in normal subjects. Electroencephalogr Clin Neurophysiol (1992) 0.90
Interaction between ACTH fragments, brain opiate receptors and morphine-induced analgesia. Eur J Pharmacol (1976) 0.90
Differential effects of melanocortin peptides on neural melanocortin receptors. Mol Pharmacol (1994) 0.90
Presynaptic localization of B-50 phosphoprotein: the (ACTH)-sensitive protein kinase substrate involved in rat brain polyphosphoinositide metabolism. Brain Res (1985) 0.90
Aging, dominance history, and social behavior in Java-monkeys (Macaca fascicularis). Neurobiol Aging (1997) 0.90
Microdetermination of phosphoinositides in a single extract. Anal Biochem (1985) 0.89